Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

被引：16
|
作者：
Georgakopoulos, Jorge R. [1 ]
Felfeli, Tina [2 ,3 ]
Drucker, Aaron M. [1 ,3 ,4 ]
Jo, Christine E. [5 ]
Piguet, Vincent [1 ,4 ]
Yeung, Jensen [1 ,6 ,7 ,8 ]
机构：
[1] Univ Toronto, Dept Med, Div Dermatol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[4] Womens Coll Hosp, Toronto, ON, Canada
[5] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[7] Prob Med Res Inc, Waterloo, ON, Canada
[8] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,Fifth Floor, Toronto, ON M5S 1B2, Canada
来源：
JAAD INTERNATIONAL | 2021年 / 4卷
关键词：
adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety;
D O I：
10.1016/j.jdin.2021.06.001
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：67 / 69
页数：3
相关论文
共 50 条
  • [41] One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate- to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis
    Lee, Hanjae
    Kim, Bo Ri
    Kim, Kyu Han
    Lee, Dong Hun
    Na, Jung Im
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (01) : 117 - 122
  • [42] 52-week evaluation of the efficacy of dupilumab for moderate to severe atopic dermatitis in clinical practice: A Canadian multicenter retrospective study
    Jo, Christine E.
    Georgakopoulos, Jorge R.
    Ladda, Matthew
    Ighani, Arvin
    Drucker, Aaron
    Mufti, Asfandyar
    Yeung, Jensen
    Piguet, Vincent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB35 - AB35
  • [43] Real-world persistence with dupilumab among adults with atopic dermatitis (AD)
    Silverberg, J.
    Guttman-Yassky, E.
    Gadkari, A.
    Kuznik, A.
    Mallya, U. G.
    Mastey, V.
    Zhang, H.
    Chen, Z.
    Chen, C.
    Korotzer, A.
    Sierka, D.
    Fenton, M. C.
    Kaur, M.
    Jalbert, J. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S116 - S116
  • [44] Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan
    Matsutani, Masako
    Imai, Yasutomo
    Inoue, Yukako
    Hosotani, Yuka
    Kusakabe, Minori
    Natsuaki, Masaru
    Yamanishi, Kiyofumi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2020, 3 (02) : 35 - 36
  • [45] Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study
    Jia, Qiqi
    Cao, Qiaozhi
    Peng, Cong
    Shui, Xinyu
    Li, Jie
    BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [46] Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population: Real-world data from a single center
    Yang, Zijing
    Wen, Wanting
    Shi, Ruofei
    Chen, Lihong
    Wang, Hailun
    Zheng, Jie
    Zhu, Haiqin
    Pan, Meng
    Zhao, Xiaoqing
    ALLERGY, 2024, 79 (05) : 1379 - 1382
  • [47] Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study
    Pezzolo, Elena
    Rossi, MariaTeresa
    Caroppo, Francesca
    Bianchelli, Tommaso
    Fortina, Anna Belloni
    Giacchetti, Alfredo
    Pinton, Piergiacomo Calzavara
    Naldi, Luigi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) : E757 - E759
  • [48] Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
    Akiyama, Shintaro
    Yokoyama, Kaoru
    Yagi, Soichi
    Shinzaki, Shinichiro
    Tsuruta, Kozo
    Yoshioka, Shinichiro
    Sako, Minako
    Shimizu, Hiromichi
    Kobayashi, Mariko
    Sakurai, Toshiyuki
    Nomura, Kei
    Shibuya, Tomoyoshi
    Takahara, Masahiro
    Hiraoka, Sakiko
    Sugai, Kyohei
    Yanai, Shunichi
    Yoshida, Atsushi
    Koroku, Miki
    Omori, Teppei
    Saruta, Masayuki
    Matsumoto, Takayuki
    Okamoto, Ryuichi
    Tsuchiya, Kiichiro
    Fujii, Toshimitsu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (11) : 1413 - 1424
  • [49] LONG-TERM EFFICACY AND SAFETY OF RISANKIZUMAB: A RETROSPECTIVE, MULTICENTER, REAL-WORLD STUDY
    Kim, Han-Na
    Woo, Bin
    Kim, Young Chan
    Kim, Dai-Hyun
    Son, Sang Wook
    Baek, Yoo Sang
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [50] Comment on "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study''
    Palacios-Garcia, Laura
    Gomez-de Castro, Celia
    Mir-Bonafe, Marc
    Calzon, Cristina
    Galache, Cristina
    Santos-Juanes, Jorge
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E81 - E82
12345